| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.23 | 0.005 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.009 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.062 | 0.04 |